Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Albertsons Companies (ACI) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Although the revenue and EPS for Albertsons Companies (ACI) give a sense of how its business performed in the quarter ended November 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Albertsons Companies, Inc. (ACI) Q3 2026 Earnings Call Transcript
Albertsons Companies is seeing early results of its deeper integration of data and artificial intelligence, and the firm expects these resources to serve as the core of its transformation efforts, executives said Wednesday (Jan. 7) during an earnings call.
Albertons reported higher third-quarter sales on the back of growth in its pharmacy and digital businesses.
Investors looking for stocks in the Consumer Products - Staples sector might want to consider either Albertsons Companies, Inc. (ACI) or Colgate-Palmolive (CL). But which of these two companies is the best option for those looking for undervalued stocks?
The mean of analysts' price targets for Albertsons Companies (ACI) points to a 36.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
Besides Wall Street's top-and-bottom-line estimates for Albertsons Companies (ACI), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended November 2025.
Albertsons Companies remains a ‘strong buy' due to deep undervaluation despite recent share price underperformance and margin pressure. Revenue is rising, driven by pharmacy and digital sales growth, but profitability is expected to decline as gross margins compress. Substantial share buybacks and prudent debt management could support EPS and improve capital allocation, even as net profits face headwinds.
While it may not be anything like the 7% to 8% inflation rate of 2022 and 2023, the consensus view is that inflation will remain above the Federal Reserve's preferred 2% target for some time to come. That makes dividend stocks more attractive, particularly those with yields that outpace the rate of inflation.